Fetal Health Locus of Control, Maternal Anxiety, and Cardiotocography in High-Risk Pregnancies

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorIstanbul Training and Research Hospital

About this trial

This prospective observational cross-sectional study aims to evaluate the relationships among fetal health locus of control (FHLC) perceptions, maternal anxiety levels, and fetal cardiotocography parameters in high-risk pregnant women. Pregnant women at 32 weeks of gestation or later who undergo routine non-stress testing (NST) at the Perinatology Outpatient Clinic will be invited to participate. On the same day as the routine NST, participants will complete the Fetal Health Locus of Control Scale and the Beck Anxiety Inventory. Associations between FHLC dimensions, maternal anxiety levels, and NST parameters, including baseline fetal heart rate, number of accelerations, reactivity, and presence of decelerations, will be evaluated.

Eligibility criteria

Qualifiers

Singleton pregnancy at 32 weeks of gestation or later

Being followed for a high-risk pregnancy

No known diagnosed psychiatric disorder and no current psychiatric medication use

Absence of a fetal condition considered likely to affect the NST tracing

Disqualifiers

Gestational age below 32 weeks and/or multiple pregnancy

Presence of a fetal condition considered likely to affect the NST tracing

Acute maternal infection or an obstetric emergency

Known diagnosed psychiatric disorder and/or current psychiatric medication use

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

150 Participants
are grouped into 1 trial group